Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Gorovits

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
The AAPS Journal|November 8, 2017
Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic DevelopmentLi Xue, Adrienne Clements-Egan, Lakshmi Amaravadi, et al.
The AAPS Journal|June 20, 2019
Anti-drug Antibody Assay Validation: Improved Reporting of the Assay Selectivity via Simpler Positive Control Recovery Data AnalysisBoris Gorovits, Marcela Araya Roldan, Daniel Baltrukonis, et al.
The AAPS Journal|January 30, 2016
Pre-existing Antibody: Biotherapeutic Modality-Based ReviewBoris Gorovits, Adrienne Clements-Egan, Mary Birchler, et al.
Journal of Pharmaceutical Sciences|April 9, 2017
Preclinical Pharmacokinetics, Pharmacodynamics, Tissue Distribution, and Interspecies Scaling of Recombinant Human Coagulation Factor Xa<sup>I16L</sup>Chuenlei Parng, Victoria Markiewicz, Jianqing Chen, et al.
Regulatory Toxicology and Pharmacology : RTP|September 10, 2013
Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncologyStanley A Roberts, Paul A Andrews, Diann Blanset, et al.
Bioanalysis|June 20, 2020
Recommendations for singlet-based approach in ligand binding assays: an IQ Consortium perspectiveRenuka Pillutla, Boris Gorovits, Carol Gleason, et al.
The AAPS Journal|September 16, 2021
Evaluation of the Humoral Response to Adeno-Associated Virus-Based Gene Therapy Modalities Using Total Antibody AssaysBoris Gorovits, Mitra Azadeh, George Buchlis, et al.
Molecular Therapy. Methods & Clinical Development|March 18, 2024
Preexisting antibody assays for gene therapy: Considerations on patient selection cutoffs and companion diagnostic requirementsManuela Braun, Claudia Lange, Philipp Schatz, et al.
The AAPS Journal|April 26, 2023
Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene TherapyBoris Gorovits, Mitra Azadeh, George Buchlis, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 11, 2008
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsGopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
The AAPS Journal|November 8, 2017
Recommendations for the Assessment and Management of Pre-existing Drug-Reactive Antibodies During Biotherapeutic DevelopmentLi Xue, Adrienne Clements-Egan, Lakshmi Amaravadi, et al.
The AAPS Journal|June 20, 2019
Anti-drug Antibody Assay Validation: Improved Reporting of the Assay Selectivity via Simpler Positive Control Recovery Data AnalysisBoris Gorovits, Marcela Araya Roldan, Daniel Baltrukonis, et al.
The AAPS Journal|January 30, 2016
Pre-existing Antibody: Biotherapeutic Modality-Based ReviewBoris Gorovits, Adrienne Clements-Egan, Mary Birchler, et al.
Journal of Pharmaceutical Sciences|April 9, 2017
Preclinical Pharmacokinetics, Pharmacodynamics, Tissue Distribution, and Interspecies Scaling of Recombinant Human Coagulation Factor Xa<sup>I16L</sup>Chuenlei Parng, Victoria Markiewicz, Jianqing Chen, et al.
Regulatory Toxicology and Pharmacology : RTP|September 10, 2013
Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncologyStanley A Roberts, Paul A Andrews, Diann Blanset, et al.
Bioanalysis|June 20, 2020
Recommendations for singlet-based approach in ligand binding assays: an IQ Consortium perspectiveRenuka Pillutla, Boris Gorovits, Carol Gleason, et al.
The AAPS Journal|September 16, 2021
Evaluation of the Humoral Response to Adeno-Associated Virus-Based Gene Therapy Modalities Using Total Antibody AssaysBoris Gorovits, Mitra Azadeh, George Buchlis, et al.
Molecular Therapy. Methods & Clinical Development|March 18, 2024
Preexisting antibody assays for gene therapy: Considerations on patient selection cutoffs and companion diagnostic requirementsManuela Braun, Claudia Lange, Philipp Schatz, et al.
The AAPS Journal|April 26, 2023
Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene TherapyBoris Gorovits, Mitra Azadeh, George Buchlis, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 11, 2008
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsGopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, et al.
Pageof 8